Income Tax Act 1995Section 67M
67M. Tax credit to medical, biotechnology or pharmaceutical companies453*
(1) Subject to this section, where a manufacturing company engaged
in medical, biotechnology or pharmaceutical sector has incurred
in an income year capital expenditure for the acquisition of
patents, it shall be allowed a tax credit by way of deduction from
the income tax otherwise payable by it of an amount equal to 100
per cent of the expenditure so incurred.
(2) Subject to subsection (3), where the deduction under subsection
(1) in respect of an income year exceeds the amount of income tax
otherwise payable for that income year, the excess may be carried
forward to the following income year.
(3) No deduction under subsection (2) in respect of an expenditure
shall be carried forward beyond a period of 5 consecutive income
years starting from the income year in which the expenditure was
made.
(4) Where a tax credit under subsection (1) has for any income year
been allowed and within 5 years following that income year –
(a) the company ceases to be engaged wholly or mainly in the
qualifying activity; or
(b) the company sells or otherwise transfers the patent,
an amount equal to the tax credit or the proportionate part of the
tax credit allowed under this section shall be included in the
income tax payable by the company in the income year in which
the cessation, sale or transfer takes place.
(5) The tax credit allowed under this section shall be in addition to
the allowances to which the company is entitled under section 63.
(6) No tax credit shall be allowed under this section to a company
where a deduction under section 67K has been claimed.
Please refer to endnotes at Appendix 1 Page 94 of 526
MRA THE INCOME TAX ACT 1995 95